These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32380760)

  • 1. Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse Models.
    Nguyen W; Nakayama E; Yan K; Tang B; Le TT; Liu L; Cooper TH; Hayball JD; Faddy HM; Warrilow D; Allcock RJN; Hobson-Peters J; Hall RA; Rawle DJ; Lutzky VP; Young P; Oliveira NM; Hartel G; Howley PM; Prow NA; Suhrbier A
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32380760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FHL1 promotes chikungunya and o'nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design.
    Ng WH; Liu X; Ling ZL; Santos CNO; Magalhães LS; Kueh AJ; Herold MJ; Taylor A; Freitas JR; Koit S; Wang S; Lloyd AR; Teixeira MM; Merits A; Almeida RP; King NJC; Mahalingam S
    Nat Commun; 2023 Oct; 14(1):6605. PubMed ID: 37884534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
    Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
    J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ
    Weber WC; Streblow ZJ; Kreklywich CN; Denton M; Sulgey G; Streblow MM; Marcano D; Flores PN; Rodriguez-Santiago RM; Alvarado LI; Rivera-Amill V; Messer WB; Hochreiter R; Kosulin K; Dubischar K; Buerger V; Streblow DN
    Vaccines (Basel); 2024 Aug; 12(8):. PubMed ID: 39204019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of MXRA8 in Ross River Virus Disease Pathogenesis.
    Ng WH; Ling ZL; Kueh AJ; Herold MJ; West NP; King NJC; Mahalingam S; Liu X
    mBio; 2023 Apr; 14(2):e0058823. PubMed ID: 37036079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model.
    Campos RK; Preciado-Llanes L; Azar SR; Kim YC; Brandon O; López-Camacho C; Reyes-Sandoval A; Rossi SL
    Front Immunol; 2020; 11():591885. PubMed ID: 33224148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine.
    Partidos CD; Paykel J; Weger J; Borland EM; Powers AM; Seymour R; Weaver SC; Stinchcomb DT; Osorio JE
    Vaccine; 2012 Jun; 30(31):4638-43. PubMed ID: 22583812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonreciprocity in CHIKV and MAYV Vaccine-Elicited Protection.
    Weber WC; Andoh TF; Kreklywich CN; Streblow ZJ; Denton M; Streblow MM; Powers JM; Sulgey G; Medica S; Dmitriev I; Curiel DT; Haese NN; Streblow DN
    Vaccines (Basel); 2024 Aug; 12(9):. PubMed ID: 39340002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus.
    Pezzi L; LaBeaud AD; Reusken CB; Drexler JF; Vasilakis N; Diallo M; Simon F; Jaenisch T; Gallian P; Sall A; Failloux AB; Weaver SC; de Lamballerie X;
    Antiviral Res; 2019 Dec; 172():104611. PubMed ID: 31545982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Linked Glycans Shape Skin Immune Responses during Arthritis and Myositis after Intradermal Infection with Ross River Virus.
    Tharmarajah K; Everest-Dass A; Vider J; Liu X; Freitas JR; Mostafavi H; Bettadapura J; von Itzstein M; West NP; Taylor A; Mahalingam S; Zaid A
    J Virol; 2022 Sep; 96(17):e0099922. PubMed ID: 36000846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest complex.
    Henss L; Yue C; Kandler J; Faddy HM; Simmons G; Panning M; Lewis-Ximenez LL; Baylis SA; Schnierle BS
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30669393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of pathogenic involvement of CCL4 and its receptor CCR5 in arthritogenic alphavirus disease.
    Hameed M; Solomon NA; Weger-Lucarelli J
    bioRxiv; 2024 Aug; ():. PubMed ID: 39131287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics.
    Pezzi L; Reusken CB; Weaver SC; Drexler JF; Busch M; LaBeaud AD; Diamond MS; Vasilakis N; Drebot MA; Siqueira AM; Ribeiro GS; Kohl A; Lecuit M; Ng LFP; Gallian P; de Lamballerie X;
    Antiviral Res; 2019 Jun; 166():66-81. PubMed ID: 30905821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 5: Entomological aspects.
    Pezzi L; Diallo M; Rosa-Freitas MG; Vega-Rua A; Ng LFP; Boyer S; Drexler JF; Vasilakis N; Lourenco-de-Oliveira R; Weaver SC; Kohl A; de Lamballerie X; Failloux AB;
    Antiviral Res; 2020 Feb; 174():104670. PubMed ID: 31812638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequencing of Historical Isolates, K-mer Mining and High Serological Cross-Reactivity with Ross River Virus Argue against the Presence of Getah Virus in Australia.
    Rawle DJ; Nguyen W; Dumenil T; Parry R; Warrilow D; Tang B; Le TT; Slonchak A; Khromykh AA; Lutzky VP; Yan K; Suhrbier A
    Pathogens; 2020 Oct; 9(10):. PubMed ID: 33081269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Barmah Forest Virus, Chikungunya Virus and Ross River Virus Antibodies among Papua New Guinea Military Personnel before 2019.
    Kizu JG; Graham M; Grant R; McCallum F; McPherson B; Auliff A; Kaminiel P; Liu W
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development.
    Tuekprakhon A; Puiprom O; Sasaki T; Michiels J; Bartholomeeusen K; Nakayama EE; Meno MK; Phadungsombat J; Huits R; Ariën KK; Luplertlop N; Shioda T; Leaungwutiwong P
    PLoS One; 2018; 13(12):e0208851. PubMed ID: 30557365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Antibody Responses to Emerging Mayaro Virus and Cocirculating Alphavirus Infections Examined by Using Structural Proteins from Nine New and Old World Lineages.
    Smith JL; Pugh CL; Cisney ED; Keasey SL; Guevara C; Ampuero JS; Comach G; Gomez D; Ochoa-Diaz M; Hontz RD; Ulrich RG
    mSphere; 2018; 3(2):. PubMed ID: 29577083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential.
    Webb EM; Azar SR; Haller SL; Langsjoen RM; Cuthbert CE; Ramjag AT; Luo H; Plante K; Wang T; Simmons G; Carrington CVF; Weaver SC; Rossi SL; Auguste AJ
    Sci Rep; 2019 Dec; 9(1):20399. PubMed ID: 31892710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alphavirus protease inhibitors from natural sources: A homology modeling and molecular docking investigation.
    Byler KG; Collins JT; Ogungbe IV; Setzer WN
    Comput Biol Chem; 2016 Oct; 64():163-184. PubMed ID: 27387412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.